The impact of pharmacogenomics on the management of cardiac disease

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Pharmacogenomics promises to help maximize efficacy and minimize adverse drug reactions. It could have a significant impact on the treatment of cardiovascular disease, the leading cause of death in the United States. The past decade has seen pharmacogenomics move from study of a candidate gene to genome-wide approaches, with the development of a series of pharmacogenetic tests. However, many barriers need to be overcome for cardiovascular pharmacogenomics to have its promised clinical impact.

Original languageEnglish (US)
Pages (from-to)493-495
Number of pages3
JournalClinical pharmacology and therapeutics
Issue number4
StatePublished - Oct 2011

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'The impact of pharmacogenomics on the management of cardiac disease'. Together they form a unique fingerprint.

Cite this